4 assets in Grade III Lymphomatoid Granulomatosis

Therapeutic assets addressing Grade III Lymphomatoid Granulomatosis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tcm-Enriched T Cells Grade III Lymphomatoid Granulomatosis	City of Hope Medical Center	P1	CC (43)